HomeAI · summaries
Storia in 4 fonti
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the opportunity.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
upi.com
FDA to consider lifting restrictions on peptide injections touted by RFK Jr. - UPI.com
The Food and Drug Administration is considering lifting restrictions on some peptide injections.
- ·
arstechnica.com
RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban
There doesn't seem to be new safety or efficacy data, but Kennedy touts them anyway.
- ·
cnbc.com
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the opportunity.
- ·
forbes.com
RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks
A physician examines whether the FDA's loosening of wellness peptide restrictions means these compounds are actually safe and proven. The answer may surprise you.